Oramed PharmaceuticalsvsUnitedHealth

ORMP and UNH stock compared: price, dividend, valuation and results, from SEC filings.

ORMP

Oramed Pharmaceuticals Inc.

$3.57

Value $155M

-3.25%
ORMP's page

UNH

UnitedHealth Group Incorporated

$339.85

Value $308B

+2.84%
UNH's page

Oramed Pharmaceuticals (ORMP) has a market value of $155M and UnitedHealth (UNH) $308B. Over the last year, with dividends, ORMP moved +52.5% and UNH +12.9%. Dividend yield: ORMP none, UNH 2.67%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ORMP$155M

    UNH$308B

    UNH is 1,987 times ORMP

  • Revenue, 12 months

    ORMP$2.0M

    UNH$450B

    UNH is 224,831 times ORMP

  • Net income, 12 months

    ORMP$145M

    UNH$15.9B

    UNH is 110 times ORMP

  • Operating margin

    ORMP-810.1%

    UNH5.3%

    815.3 points apart

  • ROIC

    ORMP-4.5%

    UNH11.3%

    15.8 points apart

  • P/E

    ORMP–

    UNH19.4

  • Dividend yield

    ORMP0.0%

    UNH2.7%

    2.7 points apart

  • 5-year return

    ORMP-85.6%

    UNH-15.4%

    70.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ORMP-85.6%

UNH-15.4%

05010015020222023202420252026
Returns by period
PeriodORMPWith dividendsUNHWith dividends
1 year since November 19, 2025+52.5%Price +42.8%+12.9%Price +10.0%
3 years since November 20, 2023+76.5%+20.9% a yearPrice +65.3%-32.4%-12.2% a yearPrice -36.5%
5 years since November 19, 2021-85.6%-32.1% a yearPrice -86.5%-15.4%-3.3% a yearPrice -22.8%
10 years since November 22, 2016-37.4%-4.6% a yearPrice -41.4%+163.6%+10.2% a yearPrice +123.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ORMPOramed PharmaceuticalsUNHUnitedHealth

Valuation

ORMPUNH
Valuation
Price$3.57$339.85
Market value$155M$308B
Enterprise value (EV)$126M$354B
P/E–19.4
P/E, 5-year median14.725.0
P/B0.53.0
EV/EBIT–14.8
Free cash flow yield–7.4%

Results and growth

ORMPUNH
Results and growth
Revenue, 12 months$2.0M$450B
Net income, 12 months$145M$15.9B
Free cash flow, 12 months-$3.2M$22.8B
Earnings per share, 12 months$3.42$17.52
Revenue growth, year on year22.2%11.8%
Revenue growth a year, past-5.9%over 5 years+11.7%over 5 years
EPS growth a year, past+21.8%over 5 years-3.8%over 5 years

Margins and returns on capital

ORMPUNH
Margins and returns on capital
Gross margin0.7%88.3%
Operating margin-810.1%5.3%
Net margin3,202.5%3.5%
ROIC-4.5%11.3%
ROE55.8%15.5%

Balance sheet

ORMPUNH
Balance sheet
Cash$30M$28.5B
Total debt$1.5M$74.3B
Net debt / EBITDA–1.6
Interest cover–6.2×

Dividends and buybacks

ORMPUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield3.1%1.8%
Shareholder yield3.1%4.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ORMP or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Oramed Pharmaceuticals or UnitedHealth?

By market value, UnitedHealth ($308B) is about 1,987.0 times Oramed Pharmaceuticals ($155M), at today's prices.

How did ORMP and UNH stock do over the last 10 years?

Since November 22, 2016, ORMP's price moved -41.4% and UNH's +123.2%. With dividends: ORMP -37.4% (-4.6% a year), UNH +163.6% (+10.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, ORMP or UNH?

The dividend yield at today's price is none for Oramed Pharmaceuticals and 2.67% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

Which has the higher profit margins, Oramed Pharmaceuticals or UnitedHealth?

Over the last twelve months, the net margin was 3,202.5% for Oramed Pharmaceuticals and 3.5% for UnitedHealth, and the operating margin -810.1% and 5.3%. Revenue was $2.0M and $450B.

Which is the better investment, Oramed Pharmaceuticals or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.